Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2,2'-((1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl))bis(6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium) Dichloride
2. Bw A938u
3. Bw-a 938u
4. Bw-a-938u
5. Bw-a938u
6. Doxacurium
7. Nuromax
1. Bw A938u Dichloride
2. Doxacurium (chloride)
3. Bw-a938u
4. 106819-53-8
5. Meso Doxacurium Chloride
6. Doxacurium Chloride [mi]
7. Doxacurium Chloride, Meso-
8. Unii-m78tvm3g5z
9. Nuromax (tn)
10. Bw-938u Dichloride
11. Doxacurium Chloride [inn]
12. Doxacurium Chloride [usan]
13. M78tvm3g5z
14. Doxacurium Chloride [vandf]
15. Doxacurium Chloride [mart.]
16. Doxacurium Chloride [who-dd]
17. Schembl1649198
18. Chembl1237099
19. Doxacurium Chloride (usan/inn)
20. Doxacurium Chloride [usan:inn]
21. Hy-a0215
22. Doxacurium Chloride [orange Book]
23. Cs-0017562
24. D00760
25. Q5303681
26. 2,2'-((1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl))bis(6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium) Dichloride
27. 83348-52-1
28. Bis[3-[6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-ium-2-yl]propyl] Butanedioate;dichloride
29. Isoquinolinium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7,8-trimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl)-, Dichloride
| Molecular Weight | 1106.1 g/mol |
|---|---|
| Molecular Formula | C56H78Cl2N2O16 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 29 |
| Exact Mass | 1104.4728398 g/mol |
| Monoisotopic Mass | 1104.4728398 g/mol |
| Topological Polar Surface Area | 163 Ų |
| Heavy Atom Count | 76 |
| Formal Charge | 0 |
| Complexity | 1540 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Neuromuscular Nondepolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)
M - Musculo-skeletal system
M03 - Muscle relaxants
M03A - Muscle relaxants, peripherally acting agents
M03AC - Other quaternary ammonium compounds
M03AC07 - Doxacurium chloride
ABOUT THIS PAGE
81
PharmaCompass offers a list of Doxacurium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Doxacurium manufacturer or Doxacurium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Doxacurium manufacturer or Doxacurium supplier.
PharmaCompass also assists you with knowing the Doxacurium API Price utilized in the formulation of products. Doxacurium API Price is not always fixed or binding as the Doxacurium Price is obtained through a variety of data sources. The Doxacurium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Doxacurium chloride [INN] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxacurium chloride [INN], including repackagers and relabelers. The FDA regulates Doxacurium chloride [INN] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxacurium chloride [INN] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Doxacurium chloride [INN] supplier is an individual or a company that provides Doxacurium chloride [INN] active pharmaceutical ingredient (API) or Doxacurium chloride [INN] finished formulations upon request. The Doxacurium chloride [INN] suppliers may include Doxacurium chloride [INN] API manufacturers, exporters, distributors and traders.
Doxacurium chloride [INN] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Doxacurium chloride [INN] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Doxacurium chloride [INN] GMP manufacturer or Doxacurium chloride [INN] GMP API supplier for your needs.
A Doxacurium chloride [INN] CoA (Certificate of Analysis) is a formal document that attests to Doxacurium chloride [INN]'s compliance with Doxacurium chloride [INN] specifications and serves as a tool for batch-level quality control.
Doxacurium chloride [INN] CoA mostly includes findings from lab analyses of a specific batch. For each Doxacurium chloride [INN] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Doxacurium chloride [INN] may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxacurium chloride [INN] EP), Doxacurium chloride [INN] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxacurium chloride [INN] USP).
